Untitled

HealthTrust presents…“The Inflation Reduction Act: What Medicare Drug Price Negotiation Means for Pharmacy”

The Inflation Reduction Act (IRA) introduced the first-ever authority for CMS to negotiate drug prices, creating significant changes to Medicare reimbursement and pharmacy operations. However, many pharmacists and pharmacy technicians have limited familiarity with negotiation eligibility criteria, timelines and downstream impacts on reimbursement, 340B considerations and manufacturer pricing strategies. As IRA implementation is ongoing, variability and uncertainty remain across practice settings. In this session, the presenter will provide an overview of the Inflation Reduction Act (IRA) and its implications
for drug pricing, Medicare reimbursement and pharmacy operations. The CMS drug price negotiation program will be reviewed, including eligibility criteria, timelines and distinctions across small-molecule drugs, biologics and biosimilars as well as an examination of inflation-based rebates, Part B and Part D reimbursement changes and potential 340B considerations. Early responses from pharmaceutical manufacturers, payors and health systems will also be discussed highlighting anticipated operational and pricing impacts as the program continues to evolve.

Learning Objectives for Pharmacists & Healthcare Executives  | At the end of this session, participants should be able to:

1. Recognize the key (Inflation Reduction Act) IRA drug pricing provisions, including negotiation eligibility and timelines.
2. Recall how IRA policies affect Medicare reimbursement and pharmacy operations.
3. Identify expected impacts of IRA implementation on pharmaceutical manufacturers, payors and health systems.

Learning Objectives for Pharmacy Techs  | At the end of this session, participants should be able to:

1. Recall how the (Inflation Reduction Act) IRA drug pricing provisions will impact a patients’ access to prescription medications.
2. Recognize how IRA policies affect Medicare reimbursement and the impact this has on patient out of pocket expenses
3. Identify expected impacts of IRA implementation to the patient population.

Presenter:

Benton Zielinski, PharmD  |  PGY2 Corporate Pharmacy Administration & Leadership Resident  |  HealthTrust/University of Tennessee Health Sciences C

Target Audience:  Pharmacists, Pharmacy Techs & Healthcare Executives

CE Credit: Approved for Healthcare Executives; pending for Pharmacy

This program is pending approval for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy & Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is pending. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

By attending “The Inflation Reduction Act: What Medicare Drug Price Negotiation Means for Pharmacy” program offered by HealthTrust, participants may earn up to <1> ACHE Qualifying Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation

Belmont University CPHS Policy on Privacy & Confidentiality: 

• All registration information for CPE activities collected in the registration system and/or on paper (e.g., sign-in sheet) is kept confidential and used only for the purpose of awarding CPE credit.
• Archived recordings of CPE activities are edited so that only the presenter’s shared screen and image are visible. Comments entered into a chat box during the CPE activity will be excluded from the recording whenever possible.
• CPHS does not share with any third party (including ineligible companies) or its agents the names or contact information of CPE learners without the explicit consent of the individual learner. If a third-party requests that information be shared with CPHS CPE participants, CPHS will receive the requested information from the third party and share it with CPE participants via CPHS’s own communication methods.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.